INTEGRAGEN news, videos and press releases
For more news please use our advanced search feature.
INTEGRAGEN - More news...
INTEGRAGEN - More news...
- IntegraGen: 2024 Revenues of €8.5m, Down 27% Compared With 2023 (+5% Excluding SeqOIA), and Cash Position of €1.9m
- IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m
- IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m
- Results for the First Half of 2022 - IntegraGen Reports Strong Revenues Growth of 35% With Profitability Improvement
- IntegraGen reports 6.4 M€ in revenues for the first half of 2022 representing 34% growth compared to H1 2021. Cash position of 4.5 M€.
- IntegraGen Reports 2021 Annual Results With a Strong Growth of 20% in Revenue From Current Operations and a Significant Profitability Improvement
- IntegraGen Reports Results for 1st Half of 2021
- IntegraGen Reports Sales of 4.8 M€ for the First Half of 2021, a 2% Increase Versus 2020, and a Cash Position of 4.3 M€
- ONCODNA Provides an Update About the Friendly Takeover Bid on INTEGRAGEN
- IntegraGen reports sales of €4.7 million in the first half of 2020, up 13%, and cash position of €5.8 million
- Agreement to File a Friendly Takeover Bid Initiated by ONCODNA on INTEGRAGEN to Acquire All Outstanding Shares at a Price of 2.20€ Per Share
- IntegraGen Announces Leading U.S. Cancer Center to Use MERCURY™ Cloud-based Tool for Oncology Sequencing Data Interpretation and Reporting
-
IntegraGen
-
IntegraGen
